Top Market Insights Stories
Market Insights
What comes with the new Alzheimer's drug?
By Judith GrahamThe FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.
Market Insights










